InvestorsObserver
×
News Home

Market Reactions to Seelos Therapeutics Inc (SEEL) Stock Getting a Bearish Rating

Wednesday, June 24, 2020 10:40 AM | InvestorsObserver Analysts

Mentioned in this article

Market Reactions to Seelos Therapeutics Inc (SEEL) Stock Getting a Bearish Rating

The market has been down on Seelos Therapeutics Inc (SEEL) stock recently. SEEL gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Seelos Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SEEL!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With SEEL Stock Today?

Seelos Therapeutics Inc (SEEL) stock is flat 0.41% while the S&P 500 is up 0.43% as of 10:38 AM on Wednesday, Jun 24. SEEL is unchanged $0.00 from the previous closing price of $1.23 on volume of 634,702 shares. Over the past year the S&P 500 is higher by 6.31% while SEEL is lower by -44.39%. SEEL lost -$0.76 per share in the over the last 12 months.

To screen for more stocks like Seelos Therapeutics Inc click here.

More About Seelos Therapeutics Inc

Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App